HIV Drug Resistance Testing by High-Multiplex "Wide"

D Katzenstein, A Zolopa, V DeGruttola, R Harrigan, S Hammer, A Phillips, J Baxter, M Miller, V Miller, M Para, D Holder, S Castillo, L Dix, J Murray, P Clevenbergh, L Pedneault, S Yerly, A Patick, R Lanier, R D'Aquila, J Mellors, M Ait-Khaled, The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan Antiviral Therapy. ,vol. 5, pp. 41- 48 ,(2000)

Annemarie M Wensing, Huldrych F Gunthard, Douglas D Richman, Victoria A Johnson, Robert W Shafer, Roger Paredes, Deenan Pillay, Vincent Calvez, Update of the drug resistance mutations in HIV-1: March 2013. Topics in antiviral medicine. ,vol. 21, pp. 6- 14 ,(2013)

Guinevere Q Lee, David R Bangsberg, Conrad Muzoora, Yap Boum, Jessica H Oyugi, Nneka Emenyonu, John Bennett, Peter W Hunt, David Knapp, Chanson J Brumme, P Richard Harrigan, Jeffrey N Martin, None, Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda AIDS Research and Human Retroviruses. ,vol. 30, pp. 896- 906 ,(2014) , 10.1089/AID.2014.0043

Richard M W Hoetelmans, Vanitha Sekar, David Back, Darunavir: pharmacokinetics and drug interactions. Antiviral Therapy. ,vol. 13, pp. 1- 13 ,(2008)

Birgitte B. Simen, Jan Fredrik Simons, Katherine Huppler Hullsiek, Richard M. Novak, Rodger D. MacArthur, John D. Baxter, Chunli Huang, Christine Lubeski, Gregory S. Turenchalk, Michael S. Braverman, Brian Desany, Jonathan M. Rothberg, Michael Egholm, Michael J. Kozal, , Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. The Journal of Infectious Diseases. ,vol. 199, pp. 693- 701 ,(2009) , 10.1086/596736

Allison K. DeLong, Mingham Wu, Diane Bennett, Neil Parkin, Zhijin Wu, Joseph W. Hogan, Rami Kantor, Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase. AIDS Research and Human Retroviruses. ,vol. 28, pp. 894- 901 ,(2012) , 10.1089/AID.2011.0120

Daniela Ram, Dena Leshkowitz, Dimitri Gonzalez, Relly Forer, Itzchak Levy, Michal Chowers, Margalit Lorber, Musa Hindiyeh, Ella Mendelson, Orna Mor, Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory Journal of Virological Methods. ,vol. 212, pp. 12- 16 ,(2015) , 10.1016/J.JVIROMET.2014.11.003

H. Ekici, S. D. Rao, A. Sonnerborg, V. L. Ramprasad, R. Gupta, U. Neogi, Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries Journal of Antimicrobial Chemotherapy. ,vol. 69, pp. 3349- 3355 ,(2014) , 10.1093/JAC/DKU278

Dawn M Dudley, Emily N Chin, Benjamin N Bimber, Sabri S Sanabani, Leandro F Tarosso, Priscilla R Costa, Mariana M Sauer, Esper G Kallas, David H O.’Connor, None, Low-Cost Ultra-Wide Genotyping Using Roche/454 Pyrosequencing for Surveillance of HIV Drug Resistance PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0036494

J. Z. Li, HIV-1 Drug-Resistant Minority Variants: Sweating the Small Stuff The Journal of Infectious Diseases. ,vol. 209, pp. 639- 641 ,(2014) , 10.1093/INFDIS/JIT656